Immunotherapy for Metastatic Kidney Cancer Shows Increased Survival
2 विचारों
• 07/10/23
0
0
एम्बेड
administrator
ग्राहकों
The immune checkpoint inhibitor Opdivo (nivolumab) has been shown to increase survival for patients with metastatic clear cell kidney cancer (also called renal cell carcinoma, or RCC).
और दिखाओ
फेसबुक टिप्पणियाँ
SORT BY-
सबसे ऊपर की टिप्पणी
-
नवीनतम टिप्पणियां